02616.HK
CStone Pharmaceuticals
HKSE · Healthcare · Biotechnology · CN
HKD 5.34
−0.84%Next report
Analyst consensus
- Next report date
- Apr 1, 2027
- EPS estimate
- -HKD 0.14
- Revenue estimate
- HKD 288.9M
Latest reported
- Last report date
- Aug 27, 2026
- EPS actual
- -HKD 0.20
- EPS estimate
- -HKD 0.22
- Revenue actual
- HKD 236.6M
- Revenue estimate
- HKD 158.2M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 1
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +10.5%
- Revenue beats (12Q)
- 1
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 27, 2026 | -HKD 0.22 | -HKD 0.20 | Beat 10.53% | HKD 236.6M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Apr 1, 2027